Friday, March 17, 2017

ASCITES--Clinical Aspects

ASCITES

INTRODUCTION:
Ascites is  abnormal collection of free fluid in the peritoneal cavity.
The term ascites is from greek origin ‘askos’ meaning bag or bladder.

Diagnostic features of Ascites:

1.Uniform distension of  abdomen
2.Flanks full (500ml)
Shifting dullness (1000ml)
Fluid thrill =massive ascites
Other associated  features:
Everted umbilicus,
umbilical hernia,
Divarication of recti,
Inguinal or epigastric hernia

Note:Absence of shifting dullness or fluid thrill or absence of both does not exclude the presence of ascites.

 Dullness in ascites

Moderate Ascites-   Flanks are dull
Large ascites (500ml)- Horse shoe shaped dullness
                                         Flanks and hypogastric regions are dull
Massive Ascites-   Whole of the abdomen is dull except for a small area over the umbilical region.

Puddles sign: to detect small volume of ascetic fluid 100ml.
Method to elicit: Patient is put in knee elbow position, keeping the diaphragm of stethoscope over the most dependent part of abdomen, flick on the flank repeatedly and lightly.
Diaphragm of stethoscope is moved gradually to the other flank.A change in the intensity and character of the note indicates fluid.
Shifting dullness: to be elicitable requires minimum of 1000 ml of free fluid
Fluid thrill _elicitable in massive ascites

Mechanism of shifting dullness:
The ascitic fluid will flow to the most dependent portion of the abdomen,
the air filled intestine will float on top of this liquid.
The technique of shifting dullness makes use of this relationship to detect the presence of ascitic fluid.

Symptoms of ascites

Increasing abdominal girth.
Shortness of breath because of elevation of diaphragm-dypnea /orthopnea
Reflux esophagitis causing heartburn
Secondary effects of ascites:
1.Pleural effusion Rt side:
 due to defect in diaphragm allowing ascetic fluid to pass into pleural space
2.IVC obstruction:
When massive ascites presses on IVC-can lead to pedal edema
3.Distended neck veins
Elevated Rt.atrial pressure following tense ascites raising the diaphragm
 

Common causes of Ascites
Hepatic cirrhosis
Malignant diseases (hepatic,peritoneal)
Cardiac failure
TB abdomen

 Learning  Points :
·         Ascites is a sign of ‘decompesated ‘liver
·         500ml  of fluid should be present before before flank dullness is detected.
·         Difficult to make out dulness in obese abdomen-diagnose by USG.
·         USG can detect as little as 100 ml of fluid in peritoneum
·         In ovarian masses characteristically flanks are resonant
·         Ascites developing in stable chronic cirrhosis,super imposed Hepatoma to be suspected.
·         Malignancy related ascites-painful


History in ascites

Chronic alcoholism
 Other Liver diseases risks-transfusion,parenteral therapy,tattoos,accupuncture
h/o alcoholic cardiomyopathy
h/o heart disease
H/o cancer- breast ,colon ,pancratic,gastric
H/o abdominal pain-malignancy related ascites,pancreatitis,infection
h/o fever ,abdominal pain-TB abdomen
h/oDM-nephrotic ascites
 h/o connective tissue disease-polyserositis
h/o hypothyroidism

Clinical examination

General examination: look for
Stigmata of liver disease-spider nevi,palmar erythema,jaundice,
Raised JVP,anemia,pedal edema
Virchow’s node-rt supraclavicular region
Firm umbilical nodule-Sister Mary Joseph’s nodule
Examination of abdomen
Inspection: contour of abdomen, movements of abdominal wall,
Skin streched and shiny, odema of skin, striae,dilated veins,position,
shape of umbilicus(smiling umbilicus),herniae(umbilical,epigastric)
Transmitted pulsation in ca.stomach,,
Palpation
Tenderness,Rigidity,
lump- intra abdominal/on abdominal wall site,size,shape,surface edges
Direction of blood flow in distended veins viscera-liver,spleen,gall bladder,kidney
Hernial orifices
Percussion:Shifting dullness,fluid thrill,puddles sign
Auscul tation:Hepatic rub,bruit
Grading of Ascites
Gr1+: only on careful exam
Gr2: Easily detectable by small volume
Gr3: obvious ascites but not  tense
Gr4: Tense ascites
ASCITES dispropotionate to edema: coditions causing
1.cirrhosis of liver
2. constrictive pericarditis
3.restrictive cardiomyopathy
4.hepatic venous occlusion
5.Tuberculous peritonitis
6.Intra abdominal tumor

INVESTIGATIONS :
1.USG ABDOMEN-Confirms ascites
2.CT Abdomen
3.Peritoneoscopy
3.LAPROSCOPY and peritoneal biopsy if undiagnosed
4.Diagnostic PARACENTESIS
5.Other routine:
TC,DC,ESR,Xray chest,abdomen
6.Liver function tests
7.Liver biopsy-in cirrhosis/malignancy of liver
8.investigations for diagnosis of portal hypertension
Differences between transudate and exudate
                Features
Transudate
Exudate
Appearance
Clear
Turbid,hemorrhagic,straw coloured
Specific gravity
Less than 1016
More than1016
Proteins
Less than30gms /L
More than 30gms/Litre
Serum ascetic fluid albumin gradient
>1.1/dl
<1.1/dl
Total cell count
low
high
Differential count
Mesothelial cells/lymphocytes
Polymorphs.lymphocytes/RBCs


ASCITIC FLUID ANALYSIS:
Points to note:
1.Gross appearance
2.Biochemical analysis
3.Microbiological with cytology

Gross appearance
transudate
exudate
cloudy –a. Infection-raised polymorphs>5000/mm3
b. purulent if >50000 cells/mm3
c. milky-chylus TGL->200mg /dl;clears on adding ether
d.Deep yellow colour-If bilirubin increased
bile stained also when there is bile duct perforation
Blood stained fluid-RBC more than10 thousand/mm3
Cell count
WBC >denotes inflammation/malignancy
Mainly polymorphs-Bacterial infection/SBP
In SBP->250cells/mm3 diagnostic
But in surgical peritonitis>10 thosand cells/mm3
Lymphocyte predominance in TB peritonitis
In malignancy cell type variable;in 20% RBC and also malignant cells seen.

Biochemical analysis
Proteins >3gms/dl in exudates
SAAB-Serum albumin minus ascetic fluid albumin
Less than1.1 in exudates

More than 1.1 in transudate
SAAB is is more useful (diuresis can affect total ascetic protein concentration)
Glucose- reduced or 0- in infected ascites
(Because it is consumed by bacteria and WBC)
Low glucose but normal cell count means intestinal contents aspiration
Enzymes-LDH normally less than 50% of serum value
In bacterial infection LDH more than serum value
It is produced by lysed WBCs.
Amylase-raised in pancreatic disease
Normal 250-1000 somayagi units per day
 Bacterial tests
Gram stain-in centrifuged specimens positive in severe infection only.
SBP-not positive because count is low
Culture if done specimen must be sent to the lab immeadiately.
AFB-often negative
Cytology for malignant cells
Positive  only if peritoneum is directly involved

Complications of Ascites

1. Spontaneous bacterial peritonitis:
Suspect In cirrhosis with ascites, going for fever, abdominal pain ,ileus ,hypotension, encephalopathy
Ascitic fluid PMN cell count->250/mm3
Culture positive-enterobacter, strept.pneumonia, S.viridans
Treament-Cefatoxime
2.Hepato renal syndrome
Progressive renal failure
Spontaneous or precipitated by diuresis, paracentesis, bleeding, or drugs.
?due to altered renal hemodynamics

Differential diagnosis for distension of abdomen

Fluid/Fat/flatus/foetus/Tumor in the abdominal cavity.

differential diagnosis of causes of ascites

1.Cirrhosis of liver:
.Signs of liver cell failure
 signs of portal hypertension         
Ascitic fluid-transudate

2.Tuberculous peritonitis
Doughy abdomen
Matted omentum and loops of intestine
Multiple palpable masses
Confirmation: peritoneal  biopsy shows tuberculous granuloma
 
3.Bacterial peritonitis
 Signs of septicemia with ascites
and a focus of infection like indwelling catheter.

4.Malignant Ascites:
Primary-stomach,colon,ovary,or other intra abdominal tumors,
Sister Joseph nodules in umbilicus
5.Pancreatic ascites
H/o acute abdominal pain radiating to the back
In chronic pancreatitis fluid leaks from the pseudo pancreatic cyst
Serum amylase raised
Ascitic amylase>1000Iu/L
Diagnosis:ERCP

6.Constrictive Pericarditis
Pulsus paradoxus;kussmauls sign
Hepatomegaly with ascites
Pericardial knock
Calcific pericardium

7.Portal vein thrombosis
Sudden rapid development of –ascites,splenomegaly,hemetemesis and melena

8.Hepatic vein thrombosis
Large tender liver
Absent hepatojugular reflux

9.Nephrotic syndrome
Initial puffiness of face
Massive protenuria
Hypercholestrolemia

Management

1.daily weight chart ,IO chart,
2.Fluid restriction -1500ml/day
3.Salt restriction2gms per day –most important initial step
4.Diuretics indicated in
Gross ascites,tense ascites,before biopsy,scan or venogram
Drugs used
Spiranolactone25mg qid,increase to maximum of 400mg/day.
Frusemide20-40mg in divided doses (may combine with spiranolactone)
Amiloride10mg/day ±frusemide/thiazide
5.Paracentesis in severe distension causing respiratory distress
6.Peritoneal shunt in intractable ascites
7. Salt free Albumin infusion
8. Treatment of the cause.
KEY TAKE HOME MESSAGE                             
1.Assessment of SAAG  helps to determine if diuretics  are likely to help.
SAAG of >1.1gm/dl  is associated with portal hypertension
2.About diuretic therapy
·         Avoid postural hypotension or fatgue from diuretic tmt  which
 is likely to produce falls ;that  is worse than having ascites
3. Abstinence from alcohol
 As a First step in treatment –convince patients to abstain from alcohol
Abstinence of few months greatly improves reversible component of ascites.

REFRACTORY ASCITES
Types:
I.                    Diuretic resistant ascites
II.                  Diuretic intractable ascites
Definition
I.                   Diuretic resistant ascites
Lack of response to high dose of diuretic i.e.
-400mg/day of spiranolactone and 160 mg/day of frusemide
-while remaining compliant with low sodium diet of 50-mmolsodium per day
- and lack of response with  weight loss of  less than200gm/day
This requires an  observation period of weeks to ensure diuretic resistance.
 Recent study shows single dose of 80 mg of IV frusemide and subsequent random
- urine sodium of less than 50mmol/l is indicates refractory ascites

II.                Diueretic-intractable ascites
Development of diuretic –induced complication like severe electrolyte disturbance,
Renal impairement,hepatic encephalopathy precluding the use of  an effective  diuretic dose.
(put in simple terms patient who cannot tolerate diuretics because of side effects)

Conditions contributing to refractory ascites
1.       Active inflammation
2.       Portal or hepatic vein thrombosis
3.       GI bleed
4.       Infection
5.       Spontaneous bacterial peritonitis
6.       Malnutrition
7.       Hepatoma
8.       Super imposed cardiac and renal disease.
9.       Hepato toxic and nephrotoxic drugs

Prognosis   poor

Treatment
I.                    Large volume paracentesis
Removal of 5 litre or more of  ascetic fluid
Total paracentesis –removal of all ascetic fluid also can be done (20L or more)
Complications of large volume paracentesis
Electrolyte imbalance ,raised serum creatinine
 Spplemental Albumin infusion  required
5gm albumin per each Litre above 5L tapped
Alternative to albumin – “Terlipressin”-avoids exposing patient to blood product


II.                    TIPS (trans jugular intrahepatic porto systemic stent shunt)
Effective in decreasing ascetic fluid reaccumulation
A flexible metal prosthesis is used to connect a branch of hepatic vein to portal vein thus reducing sinusoidal pressure
Demerit:
increased  risk of hepatic  encephalopathy.
Frequent TIPS occlusion demands careful follow up

III.                Peritonio venous shunt  (Nearly Abandoned therapy )
A surgically inserted tube connects  peritoneal cavity to superior vena cava
Tube courses subcutaneously
Allows only one way passage of ascetic fluid to SVC and so back into circulation
Demerits
Tecchnical problems like blockage of tube and others)

IV.              Recent research
 Aquaretics-Vasopressin receptor antagonist
Promote excretion of electrolyte free water
Useful in patients with ascites and hyponatremia
Not yet approved by FDA
                            
Share:

Sunday, March 12, 2017

Acute Stroke andManagement

ACUTE STROKE AND MANAGEMENT

OUTLINE OF THE TOPIC



SUMMARY

1.       Stroke is one of the leading causes of death
2.       Stroke is to be recognized in the right time for  effective treatment
3.       Acute ischemic stroke must be evaluated for IV tPA: patients not fit for it, receive Aspirin
4.       Adequate hydration and oxygenation is to be ensured
5.       Hyperglycemia, and fever are treated aggressively
6.       Treatment of blood pressure is individualized
7.       Ischemic stroke is treated with planned thrombolysis as per published guidelines
8.       Stroke etiology should be evaluated and results guide secondary stroke prevention

DEFINITION

Definition: Sudden loss of brain function caused by blockage or rupture of a blood vessel to the brain,
-with symptoms lasting for more than 24hrs
or imaging study showing acute clinically relevant  brain lesion.
Stroke is one of the three commonest causes of death in most civilized societies.

TYPES OF STOKE
1.      Ischemic Stroke          incidence 85%
2.      Hemorrhagic Stroke      incidence15%
Chart 1.Types of stroke





A.     ISCHEMIC STROKE
Entails two main mechanisms
a.      Athero thrombotic:
Plaque rupture and thrombus formation which blocks cerebral vessels
Can be large vessel thrombus or small vessel thrombus.
 Large vessel- extra cranial or intracranial large vessels.
Small vessel- perforating branches or peripheral branches
b.       Embolic:
Embolism arises from heart, or
from plaques in
 big vessels like aorta, carotid.
Embolic stroke is abrupt in onset




Sources of emboli:                                           
Usually cardiac:                                              
Left atrium in atrial fibrillation;
 Left ventricle in myocardial infarction                          
                              Other sources:-
                              Bifurcation of carotids, vertebral arteries,
                              Arch of aorta
                              Paradoxical emboli in patent foramen ovale
                           

                                       B.  HEMORRHAGIC STROKE

Accounts for 15% of strokes
Two main Types of hemorrhagic stroke:
·         Intra cerebral hemorrhage
·         Subarachnoid hemorrhage

Intra cerebral hemorrhage

    Common Sites of  deep intracerebral hemorrhage:
   Thalamus, putamen, cerebellum, brainstem
 

Subarachnoid hemorrhage

Bleeding into space between pia and arachnoid mater
Sub arachnoid hemorrhage is considered a stroke only if spontaneous;
not if due to accident or fall.
Often ushered in with severe headache plus warning signs

Commonest cause: Rupture of aneurysm of cerebral artery in
Circle of Willis; Typical site of aneurysm is bifurcation of arteries (weak point); aneurysm of diameter >7mm rupture.
Other causes;
A-V malformation in and around the brain
Chronic severe hypertension




 

  C. SPECIAL TYPES OF STROKES

A.      Transient ischemic attacks: (TIA)   synonym- mini stroke

·         Defined as brief episodic neurological deficit caused by focal brain or retinal ischemia with clinical symptoms typically lasting   less than 1hr without evidence of infarction
·         Generally lasts for 15 min to 1hr;
Patient usually recovers within 24 hrs leaving no residual deficit –
Ischemia is transient and symptoms disappear completely
·         TIA cannot be differentiated from acute stoke at the onset hence prompt evaluation is a must here also.
(If the neurological symptoms continue for >24hrs –it is defined as stroke.)
·         TIA is a warning sign for future acute stroke-greatest stroke risk in first week and 10% risk within 90 days







Chart 2.Special types of stroke


Symptoms of TIA:
·         Carotid territory TIA; - 
        Sudden mono ocular blindness
                                             Hemianesthesia, hemiperesis
                                             Transient aphasia (if dominant lobe affected)
·         Vertibrobasilar territory:
          Unconsciousness (reticular formation) Drop –attacks
                                              ‘Bilateral’ limb motor /sensory dysfunction
                                                           Diplopia, Dysarthria, vertigo, tinnitus, ataxia-
                                                     (Not as single symptom but in combination)
                                            (Dysarthria and ataxia are due to cerebellar lesion)
                                            Cortical blindness /homonymous hemianopia
Amaurosis Fugax; a special type of TIA-sudden loss of vision; resolves spontaneously: embolus from carotid occludes ophthalmic artery transiently.

 Causes, pathogenesis and types  of  TIA

Embolic TIA: arising from plaques in big vessels –aortic arch, carotids or from the heart- usually from bifurcation of common carotid.
Low flow TIA: On account of reduced perfusion pressure
e.g. sudden hypotension, cardiac arrest/cervical spondylosis on suddenly turning the neck
Lacunar TIA: due to lypohyalinosis of penetrating branches.
Natural history of TIA:
10% develop infarction in the following year
Another 10% in the next year
Greatest incidence in 3-6mths after initial TIA
A TIA should lead to immediate medical evaluation to determine its cause and
a treatment plan to prevent a stroke from occurring soon after.

A simple ABCD score to identify TIA patients who are at high and early risk of going in for stroke is available

Diagnostic point about TIA;
All symptoms start together and reach maximal intensity within seconds.
Non specific dizziness on its own is not diagnostic of TIA of posterior circulation.
Differential diagnosis of TIA:
In migraine and partial seizures symptoms build up more gradually.
In migraine typical h/o headache and aura is present
In partial seizures there are positive symptoms like tonic clonic seizures.
Also symptoms spread from one point to the rest of the limb and then to the other side but in TIA all occur at once.
In hypoglycemia, impairment or loss of consciousness may occur. But this is very uncommon in TIA.
.
Treatment of TIA: Aspirin. If AF is present -Anticoagulants .

 .B.  Lacunar infarct: Lacunar strokes
 Another special type of ischemic stroke; Sub type of thrombotic strokes
Very small ischemic infarcts measuring ½ -1cm in diameter.
Cause –local small vessel disease –occlusion of local small penetrating branches of major intra cranial arteries.
Resolution: the infarct which consists of neurons and glial tissue degenerate; eventually are absorbed by activated microglial cells. Finally a cystic cavity or glial scar remains.
Found in poorly controlled hypertensive.
Occlusions are caused by–lypohyalinisation, fibrin deposition, micro atheroma or embolism.
Final outcome: They are multiple and eventually lead to-Dementia and pseudo bulbar palsy.
Note: TIA does not cause permanent damage but lacunar infarct causes permanent damage but only in very small part of the brain.

Recognized Lacunar syndromes
·         Pure motor hemiplegia 60%   ; - Lesion in internal capsule
·         Pure sensory stroke  10%        :- lesion in thalamus
·         Dysarthric clumsy hand syndrome: lesion in base of the pons or genu of-Internal capsule. Features   : Dysarthria ,clumsiness of hand, facial weakness (contralateral)
·         Ataxic hemiparesis:  hemiperesis (or leg weakness) with ipsilateral ataxia  (pons oand  internal capsule)

Lacunar TIA -heralds lacunar infarct.

C.       Silent ischemic infarcts

Cause no symptoms
Occur in elderly especially those with hypertension and smoking risk
Lead to dementia
Indicate increased risk for future stroke

Large artery strokes

·         Large arteries that can be blocked include:
o   Internal carotid artery, Middle cerebral artery (Left/right)
Features: Contralateral hemiparesis, hemi sensory loss.
(Dysphasia if lesion on left hemisphere)
Signs of cortical dysfunction- aphasia, apraxia, agnosia, visual field defects
·         Vertebral artery(Right or left),Basilar artery
Symptoms: weakness/numbness on either side or both sides, nausea, vomiting, vertigo, ataxia,Diplopia&cranial nerve palsies(brain stem and cerebellar dysfunction
·         Aortic arch atherosclerosis; Thrombus from this can break off and block any of the above large vessels

·         Small  artery strokes :   Synonym: Lacunar infarcts

Small arteries penetrate deep into the brain; block causes any of the symptoms of ischemic stroke. Amount of brain damage is small.

Many lay persons are unable to recognize stroke symptoms though they are aware of its danger

 


 


SIGNS AND SYMPTOMS OF STROKE

OnsetAlmost always acute
In Severe cases: Sudden impaired consciousness;
 ‘Sudden severe headache’ may accompany. (Commoner in hemorrhagic than in ischemic type)

 In less severe cases:


Focal neurological deficit like
Hemiparesis
Hemi sensory loss
Mono ocular or binocular loss of vision
Defect in visual field
Diplopia
Dysarthria
dizziness
Ataxia
Vertigo
Aphasia and
Memory loss, confusion, behavioral changes
Sudden loss of bladder or bowel function



Above symptoms can occur in mild, moderate or severe degree and in any combination.
Lay people’s awareness about these symptoms is essential for reaching hospital early.

Symptoms and signs of Anterior circulation Strokes

 



Distinctive
 (of cortical dysfunction)
Aphasia
Apraxia
             Agnosia

Less specific
Unilateral numbness or weakness
Visual field defect
Dysarthria
Headache



Symptoms and signs of posterior circulation stroke

BRAINSTEM
·         Ipsilateral cranial nerve palsy with contralateral motor or sensory deficit
·         Bilateral motor /sensory deficit
·         Disordered conjugate gaze
CEREBELLUM
·         Cerebellar dysfunction without ipsilateral long tract deficit
OCCIPITAL CORTEX
·         Isolated homonymous visual field defect with macular sparing
ATAXIA
Can be from lesions of
·         Cerebellum,
·         Pons, Medulla
·         Cervical cord
VERTIGO
Hallmark symptom of VBI(Vertibro basilar artery insufficiency)
(Can result from damage to-labyrinth,vestibular nerve,central vestibular  structures   in brainstem)

DIAGNOSIS OF STROKE

Consists of:
1.Medical history,
2.General Examination including vital signs
3.Neurological examination to evaluate Anatomical and etiological diagnosis
(Refer ‘Clinical Examination in Hemiplegia ‘and
‘Diagnosis and management of hemiplegia ‘ by the same author)

DIFFERENTIALDIAGNOSIS FOR STROKE

STROKE MIMICKERS   (Disorders that mimic stroke)
1.       Seizures
2.       Tumors especially metastatic
3.       Systemic infections
4.       Toxic metabolic  disturbances
5.       Migranous aura
6.       Hypoglycemia
7.       Multiple sclerosis
8.       Intracranial hematoma(subdural,intradural)
9.       Infective  encephalitis
10.   Hyponatremia

Commonest are Seizure, Migraine and Brain tumor


Table1.DIFFERENTIAL DIAGNOSIS FOR STROKE
CLINICAL CONDITION
SIMILARITIES
DIFFERENTIATING FEATURES


SEIZURES
 Todd paralysis in immediate postictal period (without immediate resolve may  persists  for a day or fits  may  have  been unobserved by attendants or out of patient’s recall
H/o established seizure,
h/o paralysis developing  from one point to other parts gradually not all at once.
 CEREBRAL NEOPLASMS
Primary or secondary

1. hemorrhage within tumor can cause acute stroke like deterioration
2.Tumor  associated seizure activity may simulate stroke

Often focal deficit is gradual in onset
MIGRAINOUS  AURA
if aura  prolonged, can simulate stroke ;rarely
ischemic stroke can complicate migraine
Typical  h/o prior similar symptoms
Associatedheadache,nausea,vomiting,photophobia
 HYPOGLY CEMIA
 Can cause acute focal signs of stroke
But resolve rapidly with treatment
(  So think of and exclude hypoglycemia in all cases of  apparent stoke  in diabetics under treatment)
HYPERTENSIVE ENCEPHALOPATHY
Can mimic stroke
 Associated with h/o hypertension

 MULTIPLE SCLEROSIS
 May develop signs like acute stroke
 Careful history and selective diagnostic tests
INTRA CRANIAL HEMATOMA
(sub dural/epidural)
 Can manifest like stroke In chronic sub- dural hematoma
often h/o headache and h/o fluctuating level of consciousness in subdural hematoma
h/o trauma may be missing or patient if elderly and is  on warfarin

INFECTIVE ENCEPHALITIS
Can mimic acute stroke
Fever, fits, altered sensorium  and abnormal CSF findings help in differentiation.


COMPLICATIONS OF STROKE

1.       Most deadly complication:
Raised ICP -can be direct effect of cerebral edema or hematoma
Cytotoxic edema after ischemic stroke-manifests in 1-4 days
Signs of increased ICP are- altered sensorium, unequal pupils, VI th nerve palsy, papilledema
Tmt: fluid restriction,elevation of head end of bed,infuse osmotic diuretics,hyperventilation

2.       Stroke progression in25%
3.       Functional Disability with complete or partial dependence
4.    Recurrence
        5.    Seizures
Common in  
Intracerebral hemorrhage 
Subarachnoid hemorrhage
Large lesion involving cerebral cortex
Stroke induced seizures are usually controlled with a single anticonvulsant
        6. Vascular cognitive impairment or frank dementia
As per recent studies Choline esterase inhibitors may help in this condition
       7. Post stroke depression in 60% 
       8. Medical complications:
 Cardiac arrhythmias, myocardial infarction, pulmonary embolism, pneumonia, urinary infection, gastrointestinal bleeding.

INVESTIGATIONS FOR STROKE

 Urgent Imaging studies to distinguish ischemic from hemorrhagic stroke
IMAGING OPTIONS AVAILABLE
·         CT scan of the brain
·         MR I of the brain
Currently controversy exists as to which is better.
Both CT and MRI can accurately distinguish between ischemia and hemorrhage
CT -Advantages:   Available in most centers; available 24hrs
                             CT is gold standard for detecting Hemorrhage fast
In 60% infarct is detected in 3-6 hrs; all in 24 hrs.
Low cost
Primary advantage-ability to detect acute hemorrhage
 Can exclude other focal causes
CT Disadvantages:  less sensitive than MRI; Detection of early signs of ischemia is not good:
in 40% stroke may not show up to 3-6hrs; sometimes up to 48hrs.
So a repeat CT scan may be required
Small strokes may not show at all.

MRI: Advantage: It is more sensitive; can diagnose infarct missed in CT and small vessel infarcts
    Disadvantage: More time consuming:  scanning time-15 minutes or little more
Not available in all hospitals, all 24 hrs
 Patient’s preparation takes some more time
 All Patients may not be cooperative-(may not hold still during procedure)
 MRI is contraindicated in certain cases.
(if patient is unstable/If with pacemakers or implanted metal devices)
Upto 2-4 hrs MRI also may be negative for infarct signs
Currently plain CT without contrast is used as ideal first line test in many centers
NOTE: If CT already shows a stroke or cerebral edema it indicates a large stroke has occurred-which has increased risk of hemorrhage; in this situation tPA can precipitate the hemorrhage
More high quality images are available for better guidance in diagnosis and Treatment


CT/MR perfusion technique:
 Help to image two factors 1.core area of infarct 2.The ischemic penumbra
Core area -area of irreversible damage inside infarct
Penumbra is the surrounding area which could be salvaged if blood flow is restored rapidly.


 
.CT ANGIOGRAM: or MR angiogram
 Once infarction is diagnosed next to know is the vessel involved-through CT-Angiogram
This test quickly identifies large vessel occlusion and carotid stenosis;
 Thus makes urgent surgery or endovascular intervention possible.
 It is also useful in identifying the vascular territory / exact vessel involved –to facilitate intra arterial infusion of tPA
In addition can diagnose intracerebral hemorrhage.
Doppler Ultrasound of the Neck; used to check carotid plaques
Other names; carotid ultrasound/carotid duplex ultrasound
Trans cranial Doppler: Detects atherosclerotic narrowing of intracranial blood vessels
SPECTand PET (Sigle Photon Emission Computed Tomography and Positron Emission Tomography)
Using radioactive material damaged area in the brain is delineated
General Investigations
Bloodsugar, lipids, Urea, creatinine
Coagulation time
Test for thrombophilia; proteinC, proteinS, antithrombin
Anticardiolipin antibodies
Platelet count
Test for polycythemia
Test for vasculitisESR, RP, and ANCA
12lead ECG, serum Cardiac enzymes
Test for Cardiac Embolism:  ECG, HOLTER MONITORING, ECHO CARDIOGRAM, TEE/TTE






TREAMENT FOR ACUTE ISCHEMIC STROKE

Time factor in stroke therapy:
1.       Time is the most crucial factor, “TIME IS BRAIN”
2.       Prompt treatment can reverse the effects of stoke by reestablishing the blood flow.
3.        Hence history taking and evaluation must be rapid
4.       Determine the exact time of onset of the stroke
        Estimate the time period that has elapsed after onset of symptoms  
       (When was patient completely normal last of all?)
Evaluation of patient must be concluded within 60 minutes of arrival in causality.

5.       Stroke is best treated in stroke unit -A unit for organized stroke care with emergency stroke management team-outcome better,mortality is lessand hospital stay is shortened.
6.       After ruling out cerebral hemorrhage, accepted best treatment is  the administration of thrombolytic-  tPA –Tissue plasminogen activator
7.       Window period-window of opportunity to rescue the penumbra
Window period and tPA
 If patient’s criteria for selection is met with
1.      Within 0 to 3 hours of onset of symptoms- “intravenous “ thrombolytic –through vein of arm is indicated.
(The most important point in history thus is time of onset of symptoms.)

2.      Between 3 to 6 hours  of onset of symptoms –“ Intra arterial” thrombolytic - administered
i.e. intra arterial tPA is   directly infused right at the site of thrombosed blood vessel via a thin flexible catheter inserted in femoral artery
But only interventional radiologist/neurosurgeon can perform this

                3.{For posterior circulation Stroke window time may be extended up to 18 hrs    
                 (AmericanStroke association)
              4. 0-8hrs- is window for Mechanical embolectomy



                                  




MODALITIES OF ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE
                   I.            Systemic thrombolysis
                II.            Local intra arterial thrombolysis
             III.            Mechanical or non pharmacological methods of revascularization


I.       SYSTEMIC THROMBOLYSIS
1. Drug of choice t-pa
2. Route-Intravenous t-PA
3. PROTOCOL GUIDELINES
3a.Patient selection and Eligibility criteria
·         Age above 18 or older
·         Clinical diagnosis of ischemic stroke causing measurable neurological deficit
·         Time of onset of symptoms less than 3hours

3b. Contra indications for t-pa
1.      Evidence of intracranial hemorrhage on pretreatment CT
2.      Clinical features suggestive of subarachnoid hemorrhage even with normal CT
3.      Active internal bleeding
4.  Known bleeding diathesis including
5.  Platelet count<100000/ml
6.  If patient has received heparin within 48 hours and has an elevated APTT
7.  Current use of oral anticoagulants (e.g.warfarin) or recent use with an
    elevated -Prothrombin time>15 sec
8. Within previous 3 months any Intracranial surgery, serious head trauma or any serious stroke
         9. On repeated measurement systolic pressure greater than 185mmof Hg or
         diastolic pressure greater than100mmofHg at the time treatment is to begin.  
         patient requires aggressive treatment to reduce BP within these limits
10    .H/O intracranial hemorrhage and  known arteriovenous malformation or aneurysm

WARNINGS AGAINST USE OF t-PA
Only minor or rapidly improving stroke symptoms
 If patient has had major surgery or trauma excluding head trauma in the previous 14 days
Recent arterial puncture at a non compressible site.
Recent lumbar puncture.
Abnormal blood glucose <50mg or >.400 mg/dl
Post myocardial infarction pericarditis
Patient was observed to have seizures at the same time the onset of stroke symptoms were observed

3C.Dose of t-PA
            0.9mg/kg (maximum of 90mg) of t-PA,
             infused over 60minutes ,
             with 10% of total dose administered as initial Intravenous bolus over 1minute.
           Do not use cardiac dose.

                      
                        4. TREATMENT PROTOCOL                   

                                        




  4. TREATMENT PROTOCOL
4. A. Initial assessment
1. Determine whether time is available to start treatment with tPA before 3hrs
1.      Draw blood for tests while preparations are made to perform non contrast CT scan
2.      Start recording BP
3.      Neurological examination
4.      CT scan without contrast
5.      Determine if CT has evidence of hemorrhage
6.      If patient had severe head or neck pain or is somnolent or stuporous, be sure there is no evidence of subarachnoid hemorrhage
7.      If there s a significant abnormal lucency suggestive of infarction, reconsider the patient-since the stroke might have occurred earlier

4B. Review of required test results
a. Hematocrit
b. Platelets
c. Blood glucose
d. PT or APTT (in patients with recent h/o oral anticoagulants or heparin)
e. Review patient selection criteria
4C. infuse t-pa
·         Give 0.9mg/kg,10% as a bolus intravenously
·         Do not use cardiac dose
·         Do not exceed 90mg maximum dose
·         Do not give aspirin, heparin or warfarin for 24 hrs
·         Monitor the patient carefully, especially the BP; follow the BP algorithm
·         Monitor neurological sign

5. adjunctive therapy
·         No concomitant heparin, warfarin or aspirin in first 24 hrs after symptoms onset.
·         If heparin or any other anticoagulant is indicated, after 24 hrs, consider performing a noncontract-or other sensitive diagnostic imaging method to rule out any intracranial hemorrhage before starting-an anticoagulant.

6. Other general measures in treatment
(In summary give basic life support, maintain electrolytes, treat fever, infection and other comorbid conditions.)

·         Intravenous hydration with normal saline
·         Supplemental oxygen
·         Insulin for hyperglycemia
·         Antipyretics for fever
·         ECG to be performed and patient is to be put on continuous cardiac monitoring
·         No oral intake is permitted until the patient passes a swallow test with sips of water
or if arrives late but within 8hrs or along with tPA
·         Treatment of Raised intracranial tension
o   Osmotic  diuretic mannitol, Loop diuretics, Hyperventilation
·         Key clinical points in treating hypertension
High BP found after ICH or SCH should not be brought down over- enthusiastically. Reasons: 1. it could be transient acute rise consequent to bleed.
2. Damaged brain tissue needs good perfusion pressure to maintain a good blood flow.
Damaged   brain tissue has lost its ability to auto regulate.
( i.e healthy brain tissue  is able to maintain  constant blood flow rate despite varying BP levels. This called auto regulation)
Low BP hence leads to low blood flow in the recently damaged area of brain
Unless SystolicBP>220orDiastolic>120and sustained, with repeated reading do not treat for within first days.
Refer table on antihypertensive treatment   for details

Table2. ANTI HYPERTENSIVE THERAPY FOR ACUTE STROKE

BLOOD PRESSUREb


TREATMENT
IN NON THROMBOLYTIC CANDIDATES

DBP>140mmof Hg
Sodium nitroprusside 0.5µgm/kg/min)Aim for10- 20%
reduction in DBP
SBP>220,DBP>120,or MAPc>130mmHg
10-20 mg labetalold IV push over 1-2 min. May  repeat or double labetalol every 20 min to a maximum dose of 150 mg.
SBP<220,DBP>120,orMAP>130mm Hg
Emergency anti hypertensive is deferred in the absence of aortic dissection, acute myocardial infarction, severe congestive heart failure or hypertensive encephalopathy.
IN THROMBOLYTIC CANDIDATES  PRE TREATMENT

SBP>185orDBP>110mmHg
1-2 inches of nitro paste or 1-2 doses of10-20mg labetalold IV push. if BP is not reduced and maintained to<180/110mmHg the patient should not be treated with tPA.
DURING AND AFTER TREATMENT

Monitor BP for 24 hrs after starting  tmt,
Look for hypotension
BP is monitored every15 min for 2hrs,then every 30 min for 6hrs and then every 1 hr for 16 hrs
DBP>140mmHg
Sodium nitroprusside(0.5µgm/kg/min) infusion
SBP>230or DBP121to140mmHg
1)10mg labetalold IVP over1-2 minutes. May repeat or double labetalol every 10minto a maximum dose of 150mg or give the initial labetalol bolus and set a labetalol drip at 2-8mg/mintill desired BP reached
2) If BP not controlled by labetalol consider sodium nitroprusside.
SBP 180-230or DBP105- 120mmof Hg
On 2 readings 5-10min apart
10mg labetalol IVover1min. may repeat or double labetalol every 10 to 20 min to a maximum dose of 150mgor give initial labetalol bolus and start a labetalol drip at 2-8 mg/min
bAll initial blood pressures should be verified before treatment by repeating reading in5 min.
cAs estimated by 1/3rd  the sum of systolic and double diastolic pressure.
DLabetalol should be avoided in patients with asthma, cardiac failure or severe abnormalities in cardiac conduction.
Labetalol  has Short half life, easily titratable,does not increase ICP
But  nitrates-nitroprusside and nitroglycerine  can raise ICP;often avoided
ACE inhibitors –slow onset ;not first line agent in ICH
Reference;American heart Association 
If during treatment ICH is suspected clinically, stop tPA treatment
POINTS TO CONSIDER
·         Patient’s BP may decline spontaneously in first 24 hrs after stroke
·         BP reduction in acute phase should be avoided if possible.
·         BP should be maintained  high enough to maintain a cerebral perfusion pressure of >60
·         Antihypertensive drugs are withheld unless diastolic BP is >130 and SBP>220
·         When treatment indicated BP should be lowered cautiously.
In hemorrhagic stroke BP Should be maintained below 180/100 -American heart Association
After use of tPA BP -maintained at185/110

7. MECHANICAL OR NON PHARMACOLOGICAL METHODS OF REVASCULARISATION

1.        CAROTID ENDARTERECTOMY or PLACEMENT OF CAROTID STENT
2.        MERCI retriever: Mechanical Embolus Removal in Cerebral Ischemia
A mechanical cork screw shaped device is used at end of the catheter to pull out the clot
Procedure:   approved by FDA;  it an Endovascular procedure;
Limitation:  clot must be visible and accessible, small pieces may lodge further down
 But at least area of damage can be smaller
Only super specialists can perform the procedure

PATIENT AND CARE GIVER’S EDUCATION
Educate patient to recognize   stroke symptoms and to seek medical help promptly.
Post stroke depression must be detected and treated
When applicable secondary stroke prevention methods must be emphasized

STROKE CODE ALGORITHM FOR ISCHEMIC STROKE
  






Mechanical Clot busting:   Indications:  patient if unsuitable for tPA

 




PREVENTION OF STROKE

·         Hypertension is important modifiable risk factor BP is to be maintained ,140/90 to
Reduce the risk of stroke
·         For primary and secondary prevention no difference between drug classes; but
        Losartan may offer benefit beyond BP lowering.

RISK FACTORS FOR STROKE

Modifiable Risk factors:


·         Hypertension
·         Diabetes mellitus
·         High cholesterol level
·         Obesity
·         Sedentary life style
·         Smoking
·         Heavy drinking
·         Low fiber, high fat diet
·         Cardiac Disease
·         Carotid stenosis
·         Atrial fibrillation
·         TIA/prior stroke
·         Sickle cell disease, polycythemia
·         Sleep apnea


Non modifiable risk factors
·         Age above 55
·         Gender; males are more prone
·         Family history
·          Race/ethnicity: African –American race

Prevention

Aim: Prevent not only disability but also long term dementia that can occur (after silent strokes); many strokes can be prevented with the use of modern medicines

TYPES OF PREVENTION

1.       Primary prevention
2.      Secondary prevention-needs  to be aggressive
. STROKE PREVENTION IS A MULTIFACTORIAL APPROACH

                                  Table 3.  MEASURES FOR STROKE PREVENTION
PRIMARY PREVENTION
SECONDARY PREVENTION

Treat hypertension
All primary prevention treatment
Treat  hyperlipedemia
Carotid endarterectomy/stent
Quit smoking
Anticoagulation for cardiac emboli
Exercise
Antiplatelet therapy ;ASA ,CLOPIDOGREL
 ASA/extended release Dipyridamole
Detect and treat atrial fibrillation

Aspirin for  myocardial infarction and stroke


·         Treatment of risk factors prevents most strokes
·         Diet, exercise, cessation of smoking, antihypertensive, lipid lowering agents are highly  important in primary prevention
·         in secondary prevention also, same measures are important

·         Anticoagulation warfarin is for atrial fibrillation and related cardiac source of embolism.
·          For related cardio embolic strokes cardiomyopathy, MVPS, MR, aortic disease-  Aspirin.
·         Carotid endarterectomy/stenting for secondary stroke prevention if causing TIA or minor stroke
·         Anti platelet therapy for all but  for warfarin indicated patients;
·          increasing evidence for ASA and Extended Release  dipyridamole  combination ;makes a very effective combination
No evidence for ASA+clopidogrel combination but each   can be used alone; Combination increases bleeding risk. (But used in acute coronary syndrome, coronary stent patients

·         New ASA guidelines for secondary stroke prevention are published

Pharmaco therapeutic strategies for stroke prevention

HYPERTENSION
·         Hypertension -An Important stroke risk factor-increases risk by 5-6 fold
·         Treatment of hypertension is crucial in secondary prevention also
·         Anti hypertensive to be chosen for stroke prevention
o   ACE Inhibitors seem especially effective HOPE STUDY
o   perhaps a diuretic combination is more effective
o   ARB also effective
o   Time  to start treatment for hypertension after stroke
§  ARB (Candesartan) initiated on day1afterstroke has shown long term benefit.ACCESS STUDY
·         In summary ACEI or ARB + diuretic may be advantageous.
·         But control of BP is more important than choice of agent.
·         African-Americans require ACEI+DIURETIC or perhaps Calcium channel blockers
·         Detection and aggressive treatment of hypertension prevents primary stroke40-50%:
       Secondary stoke prevention 28%
·         Absolute target level of BP reduction-uncertain; Must be individualized(AHA guideline)
·         If diabetes  and hyperlipedemia associated, more vigorous control of BP  is required

DIABETES
Control to near normoglycemic levels
Vigorous treatment of hypertension and hyperlipedemia indicated
More than 1 agent may be required. First choice are ACEI and ARBs

 CHOLESTEROL AND STROKE
·          Direct correlation between cholesterol and stroke is small
·         But STATINS have shown to have Pleotropic effect: plaque stability, antithrombotic anti platelet, anti inflammatory (CRP) effect.
·         Studies show that Statins prevent stroke as well as recurrent MI
·         HPS SPARCL studies suggest Statin indication after stroke
·         FDA has  approved simvastatin 40mg /pravastatin for secondary stroke prevention
·         Should be managed according to NECP guidelines


SECONDARY STROKE PREVENTION

I.ANTICOAGULANTS 
1. WARFARIN:
Clearly benefits patients with atrial fibrillation in preventing stroke especially those with high risk. (History of CHAD-Congestive heart failure, Hypertension. age >75 Diabetes, Stroke/TIA)
 For Non cardio embolic stroke; warfarin not indicated
For recurrent Stroke: Aspirin only indicated not warfarin
2.ANTI PLATELET AGENTS
Aspirin
Combination of aspirin and extended release dypiridamole studied to be better than Aspirin alone
No evidence for aspirin and clopidogrel combination (increased risk of bleeding)

                              Table4. SECONDARY STROKE PREVENTIVE THERAPIES
                    CLASS
            AGENTS
Anticoagulant
 Warfarin only in atrial fibrillation with high risk –target INR2-3.
Antiplatelet agents
 Aspirin 160-300mg /day within 48 hrs

Aspirin+ Extended release dipyridamole
(Aspirin25mg+ dipyridamole 200mg)

Clopidogrel 75mg daily- For patients allergic to aspirin
Antihypertensives
ACEI

ARBs
Antihyperlipedemia
Statins


                          Table5.COMPARISION OF ANTIPLATELET AGENTS

CLOPIDOGREL
ASPIRIN
Aspirin with dipyridamole SR
Efficacy
+++
++
++++
Tolerability
+++
+++
++
Routine blood monitoring
NO
NO
NO
Dosing frequency
od
od
bid
Cost
++++
+
+++


SURGICAL TREATMENT OF ISCHEMIC STROKE

                                        (Also serves as secondary stroke prevention)

IA. CAROTID ENDARTERECTOMY OR STENTING
Indication:
In symptomatic carotid stenosis ≥ 70%
                           In some patient with ≥ 50% symptomatic carotid stenosis
Beneficial in selected patients
IB.  Angioplasty and Stenting
Indication: in those with high risk with unstable heart disease,
Unstable neurological status,
Contralateral occlusion
Procedure: A catheter is inserted via femoral artery into
the intra cerebral artery that is narrowed; tiny balloon at the end of
 the catheter is inflated to flatten the thrombus; a wire mesh stent is placed
to retain the artery open
·         Stenting/angioplasty is also performed for cervical arteries
II.MERCI RETRIEVER: MECHANICAL EMBOLUS REMOVAL IN CEREBRAL ISCHEMIA
·         Indication: patient if unsuitable for tPA/arrive late  but within 8hrs/companion to tPA
·         A mechanical cork screw shaped device is used at end of the catheter to pull out the clot
·         Procedure:
 An endovascular procedure;  approved by FDA;speeds up the process of  clot removal jn ischemic stroke
A mechanical cork screw shaped device is used at end of the catheter to grab and pull out the clot
·         Limitation:  clot must be visible and accessible, small pieces may lodge further down
·         But at least area of damage can be smaller
·         Only super specialists can perform the procedure






INTRA CEREBRAL HEMORRHAGE (ICH)

ICH is bleeding within the brain
Etiology:
Commonest cause   ; chronic hypertension
Less common:
Amyloidal angiopathy of cerebral vessels
Other causes;
Congenital, causes-Cerebral aneurysm, Arterio venous malformation
Traumatic or inflammatory pathology of cerebral vessel
 Tumors
Bleeding disorders, high dose anticoagulants
Others;atherosclerotic aneurysm,mycotic aneurysm,
Note: Ischemic   stroke can get transformed into hemorrhagic stroke. But they are commonly asymptomatic
Clinical presentation
 Characteristic “Severe headache”, nausea, vomiting, seizure
In old people headache may be mild or absent
 Progressive neurologic deficit-Unilateral motor/sensory loss
 Dimness/loss of vision in one eye
Neck stiffness
Impaired level of consciousness,/coma
Sudden onset, progressive
High, uncontrolled BP- systolic blood pressure greater than 220 mm Hg,
Features of high possibility of ICH: anticoagulation, hyperglycemia in a non diabetic
Neuro imaging
ICH and infarction cannot be distinguished by clinical exam alone
Neuro imaging is mandatory-CT/MRI brain
Treatment
 Best treated in stroke unit
Medical
Surgical
Currently no specific drug or surgery for ICH
Medical treatment
1. Stabilisation of the patient
2. Monitoring of blood pressure simultaneously ensuring adequate intracerebral flow
(Refer details of anti hypertensive therapy given under ischemic stroke)
3. Treatment of raised intracranial pressure
Intravenous mannitol with or without frusemide
4. for patients on warfarin and elevated INR and ICH-options available are: vitamin K
Administration of clotting factors, fresh frozen plasma, Prothrombin complex concentrate (PCC), recombinant factor VIIa

Surgical treatment-in selected cases and if refractory to medical treatment
1.      Evacuation of hematoma - moderate hematoma in awake and conscious patient
(In comatose patient and if hematoma is greater than 6cm diameter or more than 80ml with or without surgery outcome is poor; Awake patient with hematoma of less than 3cm and >20ml usually recover without surgery)
2.      Evacuation of cerebellar hematoma: prevents brainstem compression and death.
3.      For supratentorial ICH neuro surgical opinion is sought
 3. Two primary surgical treatment of cerebral aneurysm
  1. clipping: placing a metal clip across the neck of the aneurysm to prevent blood flow into aneurismal sac.
2. Coiling; tiny platinum coils are filled into aneurysm thus preventing rupture
(Aneurysm is accessed via a femoral catheter, advanced into  concerned cerebralartery)
4.      Arterio venous malformations
Three main modalities of therapy
Endovascular therapy, microsurgery, stereotactic radio surgery with gamma knife

SUB ARACHNOID HEMORRHAGE (SAH)

SAH refers to bleeding into space between pia and arachnoid
Age incidence-25-65
CAUSES OF SAH
Most common cause rupture of intracranial aneurysm, trauma
·         Head trauma –(not considered as stroke)
·         Intra cranial aneurysm cause 80% non traumatic SAH
o    Common Site – berry aneurysm of circle of Willis (MCA bifurcation, ACA,PCA )
o   Also ophthalmic  arteries, vertebral/basilar arteries
·         Benign peri midbrain hemorrhage
·         Less common causes of SAH
o   Arterio venous malformation
o   Extension from ICH
o   AV fistula, meningitis, neoplasm
Risk factors:
Hypertension, Vasculitis, fibro muscular dysplasia/o poly cystic kidney disease
                                      
Clinical presentation
Most  classical symptom: headache,(worst headache of life),abrupt, reaching maximum intensity in seconds(thunder clap headache)
Neck stiffness/signs of meningism
Nausea, vomiting, altered sensorium,
Signs of raised ICT
Intraocular/subhyaloid hemorrhage
Seizures
Sharp increase in BP (adrenaline release) cardiac arrhythmias, cardiac arrest
Neurogenic pulmonary edema
CSF may be bloody
Imaging Studies
Plain CT brain/MRI
CT Angio, MR Angio
Acute hemorrhage appears as high attenuation material (white) that fills the normally black subarachnoid space. Acute hemorrhage is most evident 2-3 days after acute bleed.
 
TREATMENT FOR SUBARACHNOID HEMORRHAGE
1.       Medical
2.      Surgical
1. Medical
Bed rest, normalizing the BP, analgesic to relieve headache plus
Nimodipine for reducing BP and for decrease brain cell loss
Nimodipine also relieves vaso spasm
2. Surgical treatment-May be required
Angiogram performed to identify source of bleeding
Common cause –aneurysm-surgical repair undertaken
Nimodipine  is shown to improve outcome in SAH
Prognosis: death or severe disability in nearly half. Survivors get neurological impairment
COMPLICATIONS
ACUTE
Chemical meningitis
Neurogenic pulmonary edema,
Brain stem herniation
Cardiac arrhythmias, myocardial infarction
Sub acute
Vasospasm cerebral ischemia
Syndrome of inappropriate ADH secretion-Hyponatremia
Chronic
Pneumonia,
Pulmonary embolism
Recurrence of SAH

Venous stroke
Bilateral involvement common
Convulsions – in 50% of cases
Common in post partum females
CSF is hemorrhagic
CT scan shows delta sign

Recurrent stroke
Arterial dissection
Patent foramen ovale
Hyperhomocysteinemia
Hypercoagulable state
Sickle cell disease
Cerebral venous thrombosis

Post stroke rehabilitation
  • Post Stroke Rehabilitation;
    • Help in recovery after stroke.
    • Help patient and family to return home after stroke.
    • Driving recommendations after stroke.
    • Depression after stroke.
    • Help patient and family understand prognosis and recovery after stroke.
    • Memory loss after stroke.
    • Recommendation of Speech Therapy
    • Occupational therapy

    Disclaimer:Please note that treatment part is not uptodate.                                              ------------------



Share:
Copyright © Academic Blog Corner for Medicos Design by VINAY VOICHAL